AGITG NABNEC: A randomised phase II study of nab-paclitaxel in combination with carboplatin as first line treatment of gastrointestinal neuroendocrine carcinomas

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Khasraw, M; Hofman, MS; Chantrill, L; Pavlakis, N; Gebski, V; Gill, AJ; Markman, B; Yip, S; Gibbs, E; Karapetis, C; Wong, SF; Ransom, DT; Michael, M; Wilson, K; Simes, J; Lipton, L

Published Date

  • September 1, 2017

Published In

Volume / Issue

  • 28 /

Published By


  • 2

Electronic International Standard Serial Number (EISSN)

  • 1569-8041

International Standard Serial Number (ISSN)

  • 0923-7534

Conference Name

  • 42nd European-Society-for-Medical-Oncology Congress (ESMO)

Conference Location

  • Madrid, SPAIN

Conference Start Date

  • September 8, 2017

Conference End Date

  • September 12, 2017